drugset / Trial / NCT06283615

Effect of Vitamin D on Skeletal Muscle Function and Qol in Patients With Chronic Intestinal Failure/Insufficiency

NCT06283615 ↗

Completed 84 enrolled Jinling Hospital, China
RandomizedParallel-groupSingle-blindTreatment

Summary

Eligible patients were randomized into two groups: Vitamin D group and Control group. Control group: received placebo plus standard care, no additional vitamin D intervention therapy. Vitamin D group: In addition to the standard care, additional intramuscular injection of vitamin D2 was given once every two weeks, each dose of 600,000 units, and the treatment lasted for 12 weeks. The primary and secondary outcomes will be collected.

Timeline

Start
2024-03-12
Primary completion
2025-03-30
Completion
2025-03-30

Outcome

Met primary endpoint

paper improvements in the appendicular skeletal muscle mass index, handgrip strength, 6-meter walking speed, and the SF-36 physical component summary score (all p < 0.05 PMID 41449463 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin D Other / unclassified 600000 iu Intramuscular